Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
about
Molecular mechanisms of prolactin and its receptorFrom obesity to cancer: a review on proposed mechanisms.Lactogens and estrogens in breast cancer chemoresistance.Estrogen action and prostate cancer.Endogenous prolactin generated during peripheral inflammation contributes to thermal hyperalgesia.Prolactin Promotes Breast Cancer Cell Migration through Actin Cytoskeleton Remodeling.Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics.Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer.Hypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specific.Prolactin--to be reconsidered in canine mammary tumourigenesis?The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications.Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.Breast carcinomas with hyperprolactinemia at the time of diagnosis-clinico-biological association.Integration of gene chip and topological network techniques to screen a candidate biomarker gene (CBG) for predication of the source water carcinogenesis risks on mouse Mus musculus.From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis.
P2860
Q27008904-B516BE07-07C9-411B-B54C-8691371FBC5CQ30241069-0C357B92-A07C-4E8C-81B5-A84052807A1AQ35075176-39BE6548-B13D-4026-82FB-85B4D3B4890CQ35099011-BCB463F1-928E-4482-BB44-633A84C69876Q35201419-D5C1C460-16FD-4186-B047-E6D9C25A3CA5Q36378657-1E6A10BB-2AF5-4217-98E5-692F79990D2EQ36793937-E8185E31-1824-45C0-85D3-A6647D00313FQ36884424-71590807-C114-4A8A-989B-FD405467BC13Q37957807-2E36D748-A59F-4573-B65D-0FE40425DE79Q38022089-0922431F-A46B-4A12-B3B9-CC4B9D5467D1Q38524488-18A404D7-D660-4221-B314-15EEB772BAB6Q38538492-F8835A7A-1455-44ED-92DB-75A2811FD400Q43706172-EE07B9D3-5D76-4DC0-AEC1-53BCCC3BDA66Q44174258-CC007C42-7023-4996-8BED-51A19DA61544Q47557119-7E065566-810A-4031-9A0E-431C12E00023
P2860
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
@ast
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
@en
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
@nl
type
label
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
@ast
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
@en
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
@nl
prefLabel
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
@ast
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
@en
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
@nl
P2093
P2860
P1476
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
@en
P2093
Eric M Jacobson
Eric R Hugo
Ruben Papoian
Traci R Tuttle
P2860
P304
P356
10.1016/J.TEM.2010.08.004
P577
2010-09-16T00:00:00Z